D&D Pharmatech Announces First Patient Dosed in Phase 1 Clinical Trial of DD01 in Obese Patients with Diabetes and NAFLD
DD01 is a long-acting dual agonist of GLP-1 and glucagon receptors, which resulted in weight…
DD01 is a long-acting dual agonist of GLP-1 and glucagon receptors, which resulted in weight…
TOKYO--(BUSINESS WIRE)--Vietnam is a nation that has seen its share of turmoil and suffering over…
Indications for renal anemia associated with chronic kidney disease in both dialysis-dependent and non-dialysis-dependent adult…
Forbes Technology Council Is an Invitation-Only Community for World-Class CIOs, CTOs, and Technology Executives. CANBERRA,…
NINGBO, China--(BUSINESS WIRE)--Student experiences are important to seek out when choosing study abroad destinations. Some…
SEOUL, South Korea--(BUSINESS WIRE)--Joonghun Pharmaceutical has officially launched their premium cross-linked hyaluronic acid dermal filler,…
SINGAPORE--(BUSINESS WIRE)--ARPA, a blockchain-based privacy-preserving computation network, released its Quarter One Update on March 24th,…
TOKYO--(BUSINESS WIRE)--Hitachi Metals, Ltd. (HML) is pleased to announce our revitalized website for 2021. The…
KUALA LUMPUR & SINGAPORE & NEW DELHI--(BUSINESS WIRE)--#AFFINBANK--Pine Labs, one of Asia’s leading merchant commerce…
OSAKA/TOKYO & SAN JOSE, Calif.--(BUSINESS WIRE)--Panasonic Corporation and McAfee Corp. (Nasdaq: MCFE), have agreed to…